RGLS

AcronymDefinition
RGLSRegular Grand Lodge of Serbia (Freemasonry)
RGLSRevenue General Ledger System
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Along with the UK's Civil Aviation Authority (CAA) Southampton set up an operational trial using a single Northern Model Runway Guard Light (RGL)--designed for 24-hour operation--that was successfully completed during the winter of 2009/10.
The lights are still operating as expected and their success prompted Southampton's management team for find other areas where solar lighting could be used and, indeed, a sixth solar RGL is already on order and much of the terminal and car park lighting has been changed to LED fittings.
Tables 3 and 4 report the RGLS estimation results for equations (1) and (2), respectively.
In addition to demonstrating that a single radial glia-like (RGL) brain cell is able to generate two very different functional cell types, the researchers followed the fates of single cells over time, finding that a single brain stem cell can even produce two stem cells like itself.
The objectives of this study were to clone, sequence, and map physically and genetically RGAs and RGLs from wheat.
A linkage map was constructed based on AFLP and RFLP markers including three resistance-gene-like (RGL) markers.
- Pascale Witz has been elected to US-based biopharmaceutical company Regulus Therapeutics Inc.'s (NASDAQ: RGLS) board of directors at its annual meeting of stockholders held late last week, the company said.
Regulus Therapeutics Inc (NASDAQ: RGLS), a biopharmaceutical company involved in the discovery and development of medicines targeting microRNAs, has named Timothy M Wright, MD as its chief research and development officer.
Regulus Therapeutics Inc (NASDAQ: RGLS), a biopharmaceutical company that is involved in the discovery and development of innovative medicines targeting microRNAs, yesterday announced its financial results for the nine months ended September 30, 2012.
(NASDAQ: RGLS), a biopharmaceutical company involved in the discovery and development of medicines targeting microRNAs, launched new pre-clinical data targeting microRNA-21 on 3 November 2012, at the American Society of Nephrology's Kidney Week 2012.
Regulus Therapeutics Inc (NASDAQ: RGLS), a biopharmaceutical company involved in the discovery and development of innovative medicines that target microRNAs, yesterday announced the pricing of its initial public offering of 11.25m shares of its common stock.
As inferred from the positions of RGL locus St1.2.4(a) and RFLP locus CPI08 tightly linked to Eca1A on linkage group I (Fig.